These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2390292)

  • 21. [Influence of chronic alcoholism on plasma 25-hydroxycholecalciferol levels].
    Paliard P; Dumeril B; Romand-Monnier M; Frederich A
    Presse Med; 1983 Feb; 12(8):503-6. PubMed ID: 6219359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of long-chain acylcarnitine.
    Rimoldi M; DiDonato S
    Neurology; 1982 Aug; 32(8):916-7. PubMed ID: 7201591
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
    Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
    Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations of ATP levels and of energy parameters in the blood of alcoholic and nonalcoholic patients with liver damage.
    Hernández-Muñoz R; Glender W; Díaz-Muñoz M; Suárez J; Lozano J; Chagoya de Sánchez V
    Alcohol Clin Exp Res; 1991 Jun; 15(3):500-3. PubMed ID: 1877735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carnitine and acylcarnitine levels of human peripheral blood lymphocytes and mononuclear phagocytes.
    Cress AP; Fraker PJ; Bieber LL
    Biochim Biophys Acta; 1989 Aug; 992(2):135-9. PubMed ID: 2474331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperprolactinemia and thyrotropin-releasing factor (TRH) responses in men with alcoholic liver disease.
    Van Thiel DH; McClain CJ; Elson MK; McMillin MJ
    Alcohol Clin Exp Res; 1978 Oct; 2(4):344-8. PubMed ID: 104634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levo-carnitine, its derivatives, and free fatty acids in serum, heart, liver, and muscle of both tumoral and alcoholic rats.
    De la Morena E; Berlanas EJ; Gomez C
    Clin Ther; 1988; 10(6):672-7. PubMed ID: 3219683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum lipoproteins in chronic alcoholics. Changes in HDL, VLDL and LDL as a function of the degree of hepatic involvement].
    Peynet J; Legrand A; Techenet P; Isal JP; Guillausseau PJ; Rousselet F
    Nouv Presse Med; 1982 Oct; 11(43):3179-83. PubMed ID: 7177834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carnitine-acylcarnitine translocase deficiency is a treatable disease.
    al Aqeel AI; Rashed MS; Wanders RJ
    J Inherit Metab Dis; 1999 May; 22(3):271-5. PubMed ID: 10384385
    [No Abstract]   [Full Text] [Related]  

  • 30. Carnitine and/or Acetylcarnitine Deficiency as a Cause of Higher Levels of Ammonia.
    Maldonado C; Guevara N; Queijo C; González R; Fagiolino P; Vázquez M
    Biomed Res Int; 2016; 2016():2920108. PubMed ID: 26998483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of free carnitine, individual short- and medium-chain acylcarnitines, and total carnitine in plasma by high-performance liquid chromatography.
    Minkler PE; Hoppel CL
    Anal Biochem; 1993 Aug; 212(2):510-8. PubMed ID: 8214594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver fibrosis in alcoholics. Detection by Fab radioimmunoassay of serum procollagen III peptides.
    Sato S; Nouchi T; Worner TM; Lieber CS
    JAMA; 1986 Sep; 256(11):1471-3. PubMed ID: 3747065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated analysis for free and short-chain acylcarnitine in plasma with a centrifugal analyzer.
    Roe DS; Terada N; Millington DS
    Clin Chem; 1992 Nov; 38(11):2215-20. PubMed ID: 1424113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Markers of hepatic fibrogenesis in alcoholic patients].
    de la Maza MP; Chichester C; Hirsch S; Petermann M; Iturriaga H; Bunout D
    Rev Med Chil; 1997 Jan; 125(1):15-21. PubMed ID: 9336064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of short- and long-term treatment with valproate on carnitine homeostasis in humans.
    Morand R; Todesco L; Donzelli M; Fischer-Barnicol D; Mullen PJ; Krähenbühl S
    Ther Drug Monit; 2012 Aug; 34(4):406-14. PubMed ID: 22743351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma lipoprotein and apolipoprotein profile in alcoholic patients with and without liver disease: on the relative roles of alcohol and liver injury.
    Duhamel G; Nalpas B; Goldstein S; Laplaud PM; Berthelot P; Chapman MJ
    Hepatology; 1984; 4(4):577-85. PubMed ID: 6430773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carnitine metabolism in patients with chronic liver disease.
    Krähenbühl S; Reichen J
    Hepatology; 1997 Jan; 25(1):148-53. PubMed ID: 8985281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon production by peripheral blood cells of patients with alcoholic liver disease (ALD).
    Daniluk J; Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 1994; 42(3):231-8. PubMed ID: 7487359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes in blood Zn, Se, Cd, Pb during therapeutic abstinence from alcohol in 101 cases of alcoholism].
    Pujatti P; Spandri P; Zotti S; Zotti GC; Giuliano G; Maccà F
    G Clin Med; 1989 Nov; 70(11):653-4, 658-60. PubMed ID: 2599287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of altered carnitine availability on acylcarnitine metabolism, energy expenditure and glucose tolerance in diet-induced obese mice.
    Schooneman MG; Houtkooper RH; Hollak CE; Wanders RJ; Vaz FM; Soeters MR; Houten SM
    Biochim Biophys Acta; 2016 Aug; 1862(8):1375-82. PubMed ID: 27112275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.